SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-23-000235
Filing Date
2023-01-05
Accepted
2023-01-05 16:29:37
Documents
2
Period of Report
2023-01-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4486
2 POA ggolumbeskipoa2019.txt EX-24 2073
  Complete submission text file 0001562180-23-000235.txt   7893
Mailing Address C/O CELGENE CORP. 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Golumbeski George (Reporting) CIK: 0001586660 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 23511720

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations